Tag: CRO
Expecto Health Science appoints Dr Pramod Kashid as its new CEO
Dr Kashid joins Expecto Health Science’s leadership team to drive clinical research innovations in emerging economies
Parexel releases 2023 ESG report, targets net-zero by 2050
In 2024, Parexel submitted science-based emission reduction targets for validation with the Science Based Target initiative (SBTi), setting a pathway to achieve net-zero value chain greenhouse gas (GHG) emissions (Scopes 1, 2, and 3) by 2050.
Emmes Group partners with Miimansa AI to accelerate adoption of Generative...
The partnership will focus on creating capabilities for quickly and accurately processing vast amounts of clinical data and enabling text to text transformations
Parexel named best CRO at 17th Annual Vaccine Industry Excellence Awards
Over the last five years Parexel has conducted more than 225 clinical projects in the infectious disease and vaccine therapeutic area involving more than 9,150 global sites
Veeda Clinical Research acquires European CRO ‘Heads’
With this acquisition, Veeda’s global pharmaceutical and biotech clients can now leverage the unique and unparalleled suite of early to late-phase CRO services across Europe, US, and Asia Pacific
Parexel named ‘Best Contract Research Organization’ at 19th Annual Scrip Awards
The company recognized with prestigious industry award by a distinguished panel of life science industry executives
Emmes appoints Peter Ronco as CEO
Peter Ronco succeeds Dr Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri, and Emmes’ Board of Directors
India’s promising CRO story
Post pandemic, Indian Contract Research Organizations have re-engineered their resources to tap the increasing demand from North America and Europe, writes Dr Kiran Marthak
Parexel rated top CRO to work with
Company receives highest average rating across all 26 performance attributes out of 34 CROs included in survey and highest net promoter score demonstrating likelihood to be recommended to colleagues
Parexel launches ‘New Medicines, Novel Insights’ expert series
New evidence-based reports offer timely analysis and actionable guidance to drug developers bringing critical new therapies to market